Birin Amin
Analyst
Piper Sandler
Equibles does not estimate personal net worth.
About Birin Amin
Birin Amin is recorded as Analyst at Piper Sandler. Birin Amin has spoken on 2 earnings calls across 2 companies, most recently for Kymera Therapeutics, Inc. on August 5, 2026. Those appearances were for Kymera Therapeutics, Inc. (KYMR) and Taysha Gene Therapies, Inc. (TSHA). The companies whose calls Birin Amin spoke on are classified in the Healthcare sector.
Birin Amin on recent calls
“It's interesting in your slide deck, you mentioned that the Broaden 2 trial data could support trials and GI indications. So, Nella, I wanted to kind of understand that.”
“Can you maybe characterize any changes from the Part A CMC material batch to Part B CMC material with, I guess, a specific emphasis on full-to-empty capsid ratio across both batches, and with the commercial scale of material, what are your thoughts in terms of how many patients you can supply into the market when…”
Affiliation history
-
Piper Sandler
Analyst
Transcript header (unverified)
Current